AI-generated summary
The authors randomly tested three photobiomodulation doses (sham, 100 J and 240 J per site, 830 nm light) in 10 adults with type 2 diabetes, with and without their usual oral medication, and measured blood glucose over 12 hours. Without medication, glucose decreased after all doses, with 100 J showing the lowest area under the curve and the effect persisting to 12 hours. With medication, decreases were similar across doses. The abstract reports only a small sample.
- Participants
- 10
- Who or what was studied
- 10 adults with type 2 diabetes mellitus
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract describes a small sample of 10 patients, and results are reported as differences between conditions without a stated statistical summary of effect size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Total energy
- 0 J, 100 J, 240 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Sham, Dose, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.